Organization Profile

You just read:

Cardiome's BRINAVESS Demonstrates 74% Cardioversion in Post-Cardiac Surgery Patients with Atrial Fibrillation

News provided by

Cardiome Pharma Corp.

Feb 13, 2014, 07:45 ET